Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Beren wins FDA approval for long-studied rare disease drug

A molecule designed by government scientists more than a decade ago has won FDA approval to treat infantile-onset Niemann-Pick disease type C, capping a winding and rocky development path. Beren Therapeutics, developer of Lembaz (adrabetadex) ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 17 November →